ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

Similar documents
Syringe driver in Palliative Care

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

SYRINGE DRIVER MEDICATIONS

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

Algorithms for Symptom Management. In End of Life Care

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

Syringe Drivers. Back to top

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

End of life prescribing guidance

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

Clatterbridge Centre for Oncology

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

Renal Palliative Care Last Days of Life

Isle of Wight Syringe Driver Compatibility Guidelines

Supportive Care. End of Life Phase

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

End Stage Liver Disease Regional Audit Casenote Survey

Palliative care for heart failure patients. Susan Addie

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Symptom Management Guidelines for End of Life Care

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure

Using syringe pumps in palliative care

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Conservative Management of Uraemia

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

Palliative Care Impact Survey

This survey aims to look at individual practice and can be completed by any healthcare professional.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

ADULT SYRINGE DRIVER PROTOCOL (T34)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Care of dying adults in the last days of life. Improving care at the very end of life.

Care in the Last Days of Life

BACKGROUND Measuring renal function :

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

MND Just in Case kit Information for GPs

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Drug Prescription and Administration Record

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Palliative Care and the Critical Role of the Pharmacist. Arti Thakerar Education/ Palliative Care Peter MacCallum Cancer Centre

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Planning for the future; A guide to symptom control at end of life in advanced dementia

Regional Renal Training

Guidelines for Syringe Driver Management in Palliative Care in New Zealand

McKinley T34 Syringe Pump Policy and Procedure

POLICY / PROCEDURE FOR THE USE OF THE McKinley T34 SYRINGE DRIVER

Access to Palliative Care Drugs and Advice through Lothian Primary Care NHS Trust Community Pharmacy Palliative Care Network

Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Administration of Drugs via the CME Medical T34 Syringe Driver Standard Operating Procedure

Implementing the recommendation on medication management and symptom control

What s New 2003? What new treatments? What have you discontinued? More information please!

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Palliative Care. Pocketbook 4

Palliative Care Formulary

Cardiac Catheter Labs Intravenous Drug Therapy Guide

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Syringe Pumps: Guidance for the use with babies, children and young people in the community setting within Worcestershire

Eastern Health and Social Services Board Palliative Care

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

SCHEDULE 2 THE SERVICES

The last days of life in hospital and at home

survey Parenteral anti-epileptics What is your experience? May July 2015

Lothian Palliative Care Guidelines POCKET EDITION 2004

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Coversheet for Network Site Specific Group Agreed Documentation

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

Appendix: Sample prescription form. The following sample prescription form gives examples of sections found in most hospital prescription forms.

Palliative care in long-term conditions Scottish Palliative Care Pharmacists Association

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Drug Administration Document for Babies, Children and Young People Requiring Symptom Management

BREATHLESSNESS MANAGEMENT

What else is new (other symptoms) DR ANDREW DAVIES

Specialist Palliative Care Audit and Guidelines Group (SPAGG)

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Adult Palliative and Supportive Care: Ambulatory Syringe Pump Policy including Symptom Management Guidelines

Opioids in the Community: Chronic pain, Palliative Care, and Addiction. Dr Ahmed Jakda September 2017

DRUG COMBINATIONS IN PALLIATIVE CARE: A COMPATIBILITY STUDY

Administration and Supply of Emergency Medicines

Target audience: The target audience for this guidance are: GPs Care home managers and nurses, District nurses, and Specialist Palliative Care teams.

A Brief Guide to Symptom Management and End of Life Care for Children During Pandemic Influenza

Palliative Prescribing - Pain

Transcription:

COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER SIGNATURE LIST Name Designation Prof. reg. no. Contact details Signature ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug / STIMULUS Problem Signature Date No Known Allergies Signature Date REGULAR MEDICATION REQUIRING ADMINISTRATION Date Freq Time DOSE words and figures Route Signature Northern England Strategic Clinical Network community prescription chart v1 1

COMMUNITY PRESCIPTION CHART If medications/ doses are stopped, cross through the relevant line clearly to avoid error. AS REQUIRED (PRN) MEDICATION Date DOSE words and figures Freq Signature Stopped sig/date PAIN/ DYSPNOEA Route eg max dose 24hrs AGITATION/ DYSPNOEA Route eg max dose 24hrs NAUSEA/ VOMITING Route eg max dose 24hrs RESPIRATY SECRETIONS Route eg max dose 24hrs Route eg max dose 24hrs Northern England Strategic Clinical Network community prescription chart v1 2

COMMUNITY PRESCIPTION CHART If medications/ doses are stopped, cross through the relevant line clearly to avoid error. AS REQUIRED (PRN) MEDICATION Date DOSE words and figures Freq Signature Stopped sig/date Route eg max dose 24hrs Route eg max dose 24hrs Route eg max dose 24hrs Route eg max dose 24hrs Route eg max dose 24hrs Route eg max dose 24hrs Route eg max dose 24hrs Northern England Strategic Clinical Network community prescription chart v1 3

COMMUNITY PRESCRIPTION CHART REGULAR MEDICATION- 24 HR CONTINUOUS SUBCUTANEOUS INFUSION DILUENT SHOULD BE STERILE WATER F MOST S UNLESS SITE IRRITATION OCCURS Date DOSE words and figures Signature Stopped sig/date Water/ Saline Water/ Saline Northern England Strategic Clinical Network community prescription chart v1 4

COMPATIBILITY CHART- based on PCF 4 Changes in the law state that the instruction / direction to mix medicines must be in writing. Therefore the prescriber must indicate in the Special Instruction column which other drug(s) to mix with in the syringe driver. As a general rule, only mix two drugs per syringe. If considering using 3 or more drugs, seek specialist advice. / INDICATION : water for injection MPHINE OXYCODONE ALFENTANIL DIAMPHINE MIDAZOLAM MIDAZOLAM Seizures CYCLIZINE Nausea and vomiting METOCLOPRAMIDE HALOPERIDOL HALOPERIDOL LEVOMEPROMAZINE LEVOMEPROMAZINE HYOSCINE BUTYLBROMIDE Chest secretions / Colic pain HYOSCINE HYDROBROMIDE Chest secretions Per 24hrs Use conversion ratio if on regular opioids 5mg (increase by 30-50% at a time) 5mg, no upper limit (increase dose by 30-50% at a time) 0.5mg (increase by 30-50% at a time) 5mg, no upper limit (increase dose by 30-50% at a time) 10mg (Increase by 30-50%) DOSE > 30mg 10mg 150mg Dilute as much as possible with water (skin irritation) 30-120mg (Dilute high doses as much as possible) PRN (Doses normally 1 hour apart, seek specialist advice if symptom control not being achieved) morphine oxycodone 250 500 microg alfentanil diamorphine COMPATIBILITY- 2 SYRINGE DRIVER YES- NOT COMPATIBLE or QUERY COMPATIBLE COMPATIBLE Alfentanil 50mg 10mg (low concentration) Morphine Alfentanil Morphine 1.5-5mg 1.5mg Alfentanil 5-30mg 1.5mg Hyoscine butlybromide 6.25-12.5mg 6.25mg Alfentanil 12.5-200mg 12.5mg Hyoscine butlybromide (Dilute high doses as much Morphine as possible) 60-120mg 20mg Alfentanil Morphine 1.2-2.4mg 400microg Morphine - incompatible at high concentration equal to or > 2mg/ml - some reports incompatible at high doses (mixes at usual concentrations) - ( + is a problematic combination therefore be cautious, dilute to 23mls and monitor). - 60mg max is 150mg/23mls - > 60mg max is 50mg/23ml - (Alfentanil high concentration) -Hysocine hydroromide no data - ( high concentration) - incompatible at high concentration (may precipitate if >2mg/ml) -Always inspect solution and discard if cloudy / crystalised -Beware with high doses -Morphine some reports incompatible at high doses of (mixes at usual concentration) - some reports incompatible -Alfentanil high concentration incompatible - high concentration incompatible - incompatible - not recommended - not recommended - some reports incompatible - (see oxycodone section) - not recommended - not recommended - not recommended - not recommended - no data - (see diamorphine section) - not recommended - no data -Morphine (see morphine section) - not recommended - not recommended - not recommended - incompatible - not recommended -Hyoscine Hydrobromide not recommended -Alfentanil no data - not recommended - not recommended Northern England Strategic Clinical Network community prescription chart v1 5